Professor | Huang Bo | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Huang Bo
Language ability	Chinese, English
Province	Beijing

Upload Avatar (500 x 500)

Name

Huang Bo

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking Union Medical College
Faculty	Basic Medical Sciences
Work Experience	Current - Beijing Union Medical College - Distinguished Professor Current - Chinese Society of Immunology - Vice Chairman and Executive Deputy Secretary-General Current - International Union of Immunological Societies (IUIS) - Education Committee Member Current - Chinese Society of Immunology Tumor Immunology and Tumor Biotherapy Committee - Chairman Current - Chinese Anti-Cancer Association Tumor Biotherapy Committee - Secretary-General

University/Lab Affiliation and Title

Peking Union Medical College

Faculty

Basic Medical Sciences

Work Experience

Current - Beijing Union Medical College - Distinguished Professor
Current - Chinese Society of Immunology - Vice Chairman and Executive Deputy Secretary-General
Current - International Union of Immunological Societies (IUIS) - Education Committee Member
Current - Chinese Society of Immunology Tumor Immunology and Tumor Biotherapy Committee - Chairman
Current - Chinese Anti-Cancer Association Tumor Biotherapy Committee - Secretary-General

Areas of Focus	Tumor Immunology Tumor Immunotherapy Tumor Metabolism Tumor Biomechanics Low-dose Cyclophosphamide Treatment Tumor Vesicle Therapy
Publications	Soft fibrin gels promote selection and growth of tumorigenic cells., Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh YC, Tang K, Wang N, Huang B, 2012 Tumor-repopulating cells transfer kynurenine to upregulate PD-1 expression in tumor-specific CD8+ T cells through AhR activation., Liu Y, Liang X, Dong W, Lv J, Fiskesund R, Xie J, Jin X, Degao Chen, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Wang J, Hu Z, Cao X, Qin F, Huang B, 2018 Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T cell memory development., Zhang H, Tang K, Ma J, Zhou L, Liu J, Zeng L, Zhu L, Xu P, Chen J, Wei K, Liang X, Lv J, Xie J, Liu Y, Wan Y, Huang B, 2020 A Pck1-directed glycogen 1 metabolic program regulates formation and maintenance of memory CD8+ T cells., Ma R, Ji T, Zhang H, Dong W, Chen X, Xu P, Chen D, Ma J, Tang K, Zhang Y, Peng Y, Lu J, Zhang Y, Qin X, Cao X, Wan Y, Huang B, 2018 Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma., Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, Jin X, Liang X, Lv J, Zhang Y, Tang K, Ma J, Zhang H, Xie J, Yao F, Tong W, Liu Y, Wang X , Huang B, 2020 Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome., Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, Xie J, Gao Y, Cheng F, Zhou Y, Zhang Z, Hu Y, Zhang X, Gao Q, Zhang Y, Huang B, 2020 J Clin Invest., Liu Y, Lv J, Liu J, Liang X, Jin X, Xie J, Chen D, Fiskesund R, Dong W, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Hu Z, Cao X, Qin F, Huang B, 2018 Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles., Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, Xu P, Sun Y, Ma R, Ji T, Chen J, Zhang S, Zhang T, Luo S, Hu Z, Cao X, Wang N, Yang X, Huang B, 2016

Areas of Focus

Tumor Immunology
Tumor Immunotherapy
Tumor Metabolism
Tumor Biomechanics
Low-dose Cyclophosphamide Treatment
Tumor Vesicle Therapy

Publications

Soft fibrin gels promote selection and growth of tumorigenic cells., Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh YC, Tang K, Wang N, Huang B*, 2012
Tumor-repopulating cells transfer kynurenine to upregulate PD-1 expression in tumor-specific CD8+ T cells through AhR activation., Liu Y, Liang X, Dong W, Lv J, Fiskesund R, Xie J, Jin X, Degao Chen, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Wang J, Hu Z, Cao X, Qin F, Huang B*, 2018
Ketogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T cell memory development., Zhang H, Tang K, Ma J, Zhou L, Liu J, Zeng L, Zhu L, Xu P, Chen J, Wei K, Liang X, Lv J, Xie J, Liu Y, Wan Y, Huang B*, 2020
A Pck1-directed glycogen 1 metabolic program regulates formation and maintenance of memory CD8+ T cells., Ma R, Ji T, Zhang H, Dong W, Chen X, Xu P, Chen D, Ma J, Tang K, Zhang Y, Peng Y, Lu J, Zhang Y, Qin X, Cao X, Wan Y, Huang B*, 2018
Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma., Gao Y, Zhang H, Zhou N, Xu P, Wang J, Gao Y, Jin X, Liang X, Lv J, Zhang Y, Tang K, Ma J, Zhang H, Xie J, Yao F, Tong W, Liu Y*, Wang X *, Huang B*, 2020
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome., Liu Y, Fang Y, Chen X, Wang Z, Liang X, Zhang T, Xie J, Gao Y, Cheng F, Zhou Y, Zhang Z, Hu Y, Zhang X, Gao Q, Zhang Y, Huang B*, 2020
J Clin Invest., Liu Y, Lv J, Liu J, Liang X, Jin X, Xie J, Chen D, Fiskesund R, Dong W, Mo S, Zhang T, Cheng F, Zhou Y, Zhang H, Hu Z, Cao X, Qin F, Huang B*, 2018
Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles., Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, Xu P, Sun Y, Ma R, Ji T, Chen J, Zhang S, Zhang T, Luo S, Hu Z, Cao X, Wang N, Yang X, Huang B*, 2016

Cancer Immunology Therapy Metabolism Biomechanics Cyclophosphamide Vesicles Treatment Research Clinical

Kong Wei - Peking University

Juan Feng - Peking University

Xiaowei Zhang - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us